Wilmington Trust National Association’s Alexion Pharmaceuticals ALXN Stock Holding History

Wilmington Trust National Association’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$635K	Sell	4,063 -328	-7%	-$51.8K	0.02%	328
2014 Q1	$668K	Sell	4,391 -528	-11%	-$84K	0.02%	309
2013 Q4	$653K	Sell	4,919 -139	-3%	-$16.7K	0.02%	304
2013 Q3	$588K	Sell	5,058 -994	-16%	-$109K	0.02%	311
2013 Q2	$558K	Buy	+6,052	New	+$583K	0.02%	311

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Trust National Association's ALXN Position: Q2 2014 in Review

Wilmington Trust National Association reduced its Alexion Pharmaceuticals (ALXN) stake by 7.5% in Q2 2014, selling an estimated $51.8K and leaving 4,063 shares worth $635K. The position accounts for 0.02% of the portfolio, ranked #328.

Wilmington Trust National Association first reported a position in ALXN in Q2 2013 and has held it in 5 quarters since. The position peaked at $668K in Q1 2014. 521 funds tracked by Wall St. Rank hold ALXN as of Q2 2014.

Wilmington Trust National Association held 4,063 shares of Alexion Pharmaceuticals worth $635K as of Q2 2014.
Wilmington Trust National Association sold 328 Alexion Pharmaceuticals shares in Q2 2014, an estimated $51.8K.
Alexion Pharmaceuticals made up 0.02% of Wilmington Trust National Association's portfolio in Q2 2014, its #328 holding.
Wilmington Trust National Association first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
Wilmington Trust National Association's Alexion Pharmaceuticals position peaked at $668K in Q1 2014.
521 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.